Form 10-K NovaBay Pharmaceuticals, For: Dec 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 falls from record high as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
NovaBay Pharma (NBY) Misses Q4 EPS by 2c
March 26, 2015 9:28 AM EDTNovaBay Pharma (NYSE: NBY) reported Q4 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $385 thousand versus the consensus estimate of $60 thousand.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
... More